Market Overview:
The global cervical cancer diagnostic tests market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The market is segmented by type, application, and region. By type, the market is segmented into Pap smear tests, colposcopy, HPV testing, endocervical curettage (ECC), cone biopsy, and others. The Pap smear test segment accounted for the largest share of the global cervical cancer diagnostic tests market in 2017 and is projected to grow at a CAGR of 7.8% from 2018 to 2030.
Product Definition:
A cervical cancer diagnostic test is a procedure used to screen for and diagnose cervical cancer. The most common type of cervical cancer screening test is the Pap smear, which uses a sample of cells taken from the cervix to look for abnormalities that may be precancerous or cancerous.
Pap Smear Tests:
Pap smear tests are used for the diagnosis of abnormal cells in the cervix. These tests are performed on a routine basis by women aged between 21 and 29 years, to detect precancerous changes in the cervix. The test is an easy and painless procedure, which can be conducted at healthcare facilities as well as at home.
Colposcopy:
Colposcopy is a medical procedure wherein the doctor inspects the vulva for abnormal changes. It's an internal examination of the vagina and it allows doctors to detect cervical cancer, STDs, infections, skin tags, etc. during its routine check-up. Colposcopes are used in cervical cancer screening tests as they provide clear images of tissues and cells lining the vaginal canal which helps in making a diagnosis easier.
Application Insights:
Based on application, the global market is segmented into hospitals, ambulatory surgical centers (ASCs), specialty clinics and others. Hospitals held the largest share in 2017 owing to factors such as availability of advanced healthcare facilities and highly skilled medical staffs. Furthermore, a large number of government initiatives that aim to improve women¢â‚¬â„¢s health services across various countries has further propelled growth in this segment.
Specialty clinics are anticipated to witness lucrative growth over the forecast period due to increasing demand for high-quality diagnostic tests by patients seeking treatment for Cervical Cancer at an early stage. Moreover, growing awareness about available diagnostic options among women as well as their families will boost revenue generation in this segment during the forecast period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the high prevalence of this disease, increasing awareness about early diagnosis, availability of technologically advanced products and presence of key players in this region. In addition, government initiatives and programs are also being undertaken to create awareness about cervical cancer screening tests and its associated benefits. For instance, as part of its national public health action plan for women's health established by the Ministry of Health Labor & Welfare (Japan), government is conducting various activities such as establishment of maternal-child care centers that provide free pregnancy testing services along with other preventive services for mothers at risk.
Growth Factors:
- Increasing incidence of cervical cancer: The incidence of cervical cancer is increasing at a fast pace across the globe. This is primarily attributed to the changing lifestyle and growing population. This, in turn, is expected to boost the demand for cervical cancer diagnostic tests over the forecast period.
- Rising awareness about early detection of cervical cancer: There is a growing awareness among women about the importance of early detection of cervical cancer. This is likely to fuel demand for diagnostic tests for cervical cancer in the coming years.
- Technological advancements in diagnosis and treatment: The diagnosis and treatment of cervical cancer has witnessed significant advancements in recent years owing to technological advancements such as introduction of HPV vaccines and molecular diagnostics techniques etcetera .This is anticipated to propel growth prospects for global Cervical Cancer Diagnostic Tests market during forecast period 2017-2025 .
Scope Of The Report
Report Attributes
Report Details
Report Title
Cervical Cancer Diagnostic Tests Market Research Report
By Type
Pap Smear Tests, Colposcopy, HPV Testing, Endocervical Curettage (ECC), Cone Biopsy, Others
By Application
Hospitals, Ambulatory surgical centers, Specialty clinics
By Companies
QIAGEN, Hologic, Roche, Becton Dickinson, Quest Diagnostic, Abbott Pathology
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
174
Number of Tables & Figures
122
Customization Available
Yes, the report can be customized as per your need.
Global Cervical Cancer Diagnostic Tests Market Report Segments:
The global Cervical Cancer Diagnostic Tests market is segmented on the basis of:
Types
Pap Smear Tests, Colposcopy, HPV Testing, Endocervical Curettage (ECC), Cone Biopsy, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Ambulatory surgical centers, Specialty clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- QIAGEN
- Hologic
- Roche
- Becton Dickinson
- Quest Diagnostic
- Abbott Pathology
Highlights of The Cervical Cancer Diagnostic Tests Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Pap Smear Tests
- Colposcopy
- HPV Testing
- Endocervical Curettage (ECC)
- Cone Biopsy
- Others
- By Application:
- Hospitals
- Ambulatory surgical centers
- Specialty clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cervical Cancer Diagnostic Tests Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cervical cancer diagnostic tests are procedures used to determine if cervical cancer is present. These tests may include a Pap test, HPV test, or colposcopy.
Some of the major companies in the cervical cancer diagnostic tests market are QIAGEN, Hologic, Roche, Becton Dickinson, Quest Diagnostic, Abbott Pathology.
The cervical cancer diagnostic tests market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cervical Cancer Diagnostic Tests Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Cervical Cancer Diagnostic Tests Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Cervical Cancer Diagnostic Tests Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Cervical Cancer Diagnostic Tests Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Cervical Cancer Diagnostic Tests Market Size & Forecast, 2020-2028 4.5.1 Cervical Cancer Diagnostic Tests Market Size and Y-o-Y Growth 4.5.2 Cervical Cancer Diagnostic Tests Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Pap Smear Tests
5.2.2 Colposcopy
5.2.3 HPV Testing
5.2.4 Endocervical Curettage (ECC)
5.2.5 Cone Biopsy
5.2.6 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Ambulatory surgical centers
6.2.3 Specialty clinics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cervical Cancer Diagnostic Tests Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cervical Cancer Diagnostic Tests Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Pap Smear Tests
9.6.2 Colposcopy
9.6.3 HPV Testing
9.6.4 Endocervical Curettage (ECC)
9.6.5 Cone Biopsy
9.6.6 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Ambulatory surgical centers
9.10.3 Specialty clinics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Pap Smear Tests
10.6.2 Colposcopy
10.6.3 HPV Testing
10.6.4 Endocervical Curettage (ECC)
10.6.5 Cone Biopsy
10.6.6 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Ambulatory surgical centers
10.10.3 Specialty clinics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Pap Smear Tests
11.6.2 Colposcopy
11.6.3 HPV Testing
11.6.4 Endocervical Curettage (ECC)
11.6.5 Cone Biopsy
11.6.6 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Ambulatory surgical centers
11.10.3 Specialty clinics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Pap Smear Tests
12.6.2 Colposcopy
12.6.3 HPV Testing
12.6.4 Endocervical Curettage (ECC)
12.6.5 Cone Biopsy
12.6.6 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Ambulatory surgical centers
12.10.3 Specialty clinics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Pap Smear Tests
13.6.2 Colposcopy
13.6.3 HPV Testing
13.6.4 Endocervical Curettage (ECC)
13.6.5 Cone Biopsy
13.6.6 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Ambulatory surgical centers
13.10.3 Specialty clinics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cervical Cancer Diagnostic Tests Market: Competitive Dashboard
14.2 Global Cervical Cancer Diagnostic Tests Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 QIAGEN
14.3.2 Hologic
14.3.3 Roche
14.3.4 Becton Dickinson
14.3.5 Quest Diagnostic
14.3.6 Abbott Pathology